These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 7524542)

  • 21. Quantification of HIV-1 RNA during antiretroviral therapy: association with viral phenotype and development of resistance.
    Katzenstein TL; Nielsen C; Bruun L; Mathiesen LR; Pedersen C; Gerstoft J
    Antivir Ther; 1996 Dec; 1(4):246-54. PubMed ID: 11324827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of transmitted nucleoside analogue-resistant HIV-1 strains and pre-existing mutations in pol reverse transcriptase and protease region: outcome after treatment in recently infected individuals.
    Balotta C; Berlusconi A; Pan A; Violin M; Riva C; Colombo MC; Gori A; Papagno L; Corvasce S; Mazzucchelli R; Facchi G; Velleca R; Saporetti G; Galli M; Rusconi S; Moroni M
    Antivir Ther; 2000 Mar; 5(1):7-14. PubMed ID: 10846586
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A mutation in human immunodeficiency virus reverse transcriptase and decline in CD4 lymphocyte numbers in long-term zidovudine recipients.
    Kozal MJ; Shafer RW; Winters MA; Katzenstein DA; Merigan TC
    J Infect Dis; 1993 Mar; 167(3):526-32. PubMed ID: 7680058
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV-1 biological phenotype and the development of zidovudine resistance in relation to disease progression in asymptomatic individuals during treatment.
    Boucher CA; Lange JM; Miedema FF; Weverling GJ; Koot M; Mulder JW; Goudsmit J; Kellam P; Larder BA; Tersmette M
    AIDS; 1992 Nov; 6(11):1259-64. PubMed ID: 1282015
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary infection with zidovudine-resistant HIV.
    Hermans P; Sprecher S; Clumeck N
    N Engl J Med; 1993 Oct; 329(15):1123; author reply 1124. PubMed ID: 8371738
    [No Abstract]   [Full Text] [Related]  

  • 26. [The sexual transmission of zidovudine-resistant HIV-1 strains].
    Ruiz L; Clotet B
    Med Clin (Barc); 1995 Oct; 105(12):476-7. PubMed ID: 7490942
    [No Abstract]   [Full Text] [Related]  

  • 27. Molecular aspect of HIV-1 resistance to zidovudine and its reversal.
    Camsonne R; Bigot MC; Bustany P; Pottier D; Vergnaud M
    Trends Pharmacol Sci; 1994 May; 15(5):137-8. PubMed ID: 7538701
    [No Abstract]   [Full Text] [Related]  

  • 28. Detection of mutations associated with zidovudine resistance in human immunodeficiency virus by use of the polymerase chain reaction.
    Richman DD; Guatelli JC; Grimes J; Tsiatis A; Gingeras T
    J Infect Dis; 1991 Dec; 164(6):1075-81. PubMed ID: 1720152
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heterosexual transmission of human immunodeficiency virus type 1 variants associated with zidovudine resistance.
    Conlon CP; Klenerman P; Edwards A; Larder BA; Phillips RE
    J Infect Dis; 1994 Feb; 169(2):411-5. PubMed ID: 7508970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emergence and clinical relevance of mutations associated with zidovudine resistance in asymptomatic HIV-1 infected patients.
    Calderón EJ; Torres Y; Medrano FJ; Luque F; Larder B; Rey C; Sánchez-Quijano A; Lissen E; Leal M
    Eur J Clin Microbiol Infect Dis; 1995 Jun; 14(6):512-9. PubMed ID: 7588824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Zidovudine resistance reverse transcriptase mutations during didanosine monotherapy.
    Shafer RW; Winters MA; Jellinger RM; Merigan TC
    J Infect Dis; 1996 Aug; 174(2):448-9. PubMed ID: 8699089
    [No Abstract]   [Full Text] [Related]  

  • 32. Sequence analysis of an HIV-1 isolate which displays unusually high-level AZT resistance in vitro.
    Muckenthaler M; Gunkel N; Levantis P; Broadhurst K; Goh B; Colvin B; Forster G; Jackson GG; Oxford JS
    J Med Virol; 1992 Feb; 36(2):79-83. PubMed ID: 1374791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ordered appearance of zidovudine resistance mutations during treatment of 18 human immunodeficiency virus-positive subjects.
    Boucher CA; O'Sullivan E; Mulder JW; Ramautarsing C; Kellam P; Darby G; Lange JM; Goudsmit J; Larder BA
    J Infect Dis; 1992 Jan; 165(1):105-10. PubMed ID: 1370174
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevalence and clinical significance of zidovudine resistance mutations in human immunodeficiency virus isolated from patients after long-term zidovudine treatment. AIDS Clinical Trials Group 116B/117 Study Team and the Virology Committee Resistance Working Group.
    Japour AJ; Welles S; D'Aquila RT; Johnson VA; Richman DD; Coombs RW; Reichelderfer PS; Kahn JO; Crumpacker CS; Kuritzkes DR
    J Infect Dis; 1995 May; 171(5):1172-9. PubMed ID: 7538548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emergence of mutant HIV reverse transcriptase conferring resistance to AZT.
    Richman DD
    J Enzyme Inhib; 1992; 6(1):55-64. PubMed ID: 1285303
    [No Abstract]   [Full Text] [Related]  

  • 36. Increase in the frequency of mutation at codon 215 associated with zidovudine resistance in HIV-1-infected antiviral-naive patients from 1989 to 1996.
    Rubio A; Leal M; Pineda JA; Caruz A; Luque F; Rey C; Sanchez-Quijano A; Lissen E
    AIDS; 1997 Jul; 11(9):1184-6. PubMed ID: 9233468
    [No Abstract]   [Full Text] [Related]  

  • 37. Transmission of zidovudine-resistant human immunodeficiency virus type 1 variants following deliberate injection of blood from a patient with AIDS: characteristics and natural history of the virus.
    Veenstra J; Schuurman R; Cornelissen M; van't Wout AB; Boucher CA; Schuitemaker H; Goudsmit J; Coutinho RA
    Clin Infect Dis; 1995 Sep; 21(3):556-60. PubMed ID: 8527543
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug-resistant virus tracked through 3 men.
    AIDS Alert; 2002 Jun; 17(6):77-8. PubMed ID: 12056219
    [No Abstract]   [Full Text] [Related]  

  • 39. Detection of zidovudine-resistant variants of HIV-1 in genital fluids.
    Wainberg MA; Beaulieu R; Tsoukas C; Thomas R
    AIDS; 1993 Mar; 7(3):433-4. PubMed ID: 8097097
    [No Abstract]   [Full Text] [Related]  

  • 40. [Experimental use of a variant of the human immunodeficiency virus (HIV-1) with decreased sensitivity to 3'-azido-2',3'-dideoxythymidine and a study of its properties].
    Selimova LM; Galegov GA
    Dokl Akad Nauk; 1995 Oct; 344(4):562-4. PubMed ID: 8590871
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.